Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity

This publication has 38 references indexed in Scilit:

• Is Activation of the Sympathetic Nervous System Beneficial or Detrimental to the Patient with Chronic Heart Failure? Lessons Learned from Clinical Trials with β-Adrenergic Agonists and Antagonists
  Journal of Cardiovascular Pharmacology, 1989
• Subsensitivity of the Failing Human Heart to Isoprenaline and Milrinoneo is Related to β-Adrenoceptor Downregulation
  Journal of Cardiovascular Pharmacology, 1988
• Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium
  European Heart Journal, 1988
• Long-term effects of xamoterol on left ventricular diastolic function and late remodeling: a study in patients with anterior myocardial infarction and single-vessel disease.
  Circulation, 1988
• Hemodynamic effects of the beta 1-adrenoceptor partial agonist xamoterol in relation to plasma norepinephrine levels during exercise in patients with left ventricular dysfunction.
  Circulation, 1987
• Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.
  Circulation Research, 1986
• The effects of beta1-adrenoceptor partial agonist ICI 118.587 on left ventricular function in patients with coronary heart disease
  International Journal of Cardiology, 1984
• Effects of a cardioselective beta1 partial agonist (corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarction
  The American Journal of Cardiology, 1983
• THE CARDIOVASCULAR EFFECTS OF ICI 118,587: A β₁‐ADRENOCEPTOR PARTIAL AGONIST
  British Journal of Pharmacology, 1982
• Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
  New England Journal of Medicine, 1982